Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cells

Acta Physiol (Oxf). 2016 May;217(1):45-60. doi: 10.1111/apha.12631. Epub 2015 Dec 9.

Abstract

Aim: Some health benefits of exercise may be explained by an altered secretion of myokines. Because previous focus has been on upregulated myokines, we screened for downregulated myokines and identified myostatin. We studied the expression of myostatin in relation to exercise and dysglycaemia in skeletal muscle, adipose tissue and plasma. We further examined some effects of myostatin on energy metabolism in primary human muscle cells and Simpson-Golabi-Behmel syndrome (SGBS) adipocytes.

Methods: Sedentary men with or without dysglycaemia underwent a 45-min acute bicycle test before and after 12 weeks of combined endurance and strength training. Blood samples and biopsies from m. vastus lateralis and adipose tissue were collected.

Results: Myostatin mRNA expression was reduced in skeletal muscle after acute as well as long-term exercise and was even further downregulated by acute exercise on top of 12-week training. Furthermore, the expression of myostatin at baseline correlated negatively with insulin sensitivity. Myostatin expression in the adipose tissue increased after 12 weeks of training and correlated positively with insulin sensitivity markers. In cultured muscle cells but not in SGBS cells, myostatin promoted an insulin-independent increase in glucose uptake. Furthermore, muscle cells incubated with myostatin had an enhanced rate of glucose oxidation and lactate production.

Conclusion: Myostatin was differentially expressed in the muscle and adipose tissue in relation to physical activity and dysglycaemia. Recombinant myostatin increased the consumption of glucose in human skeletal muscle cells, suggesting a complex regulatory role of myostatin in skeletal muscle homeostasis.

Keywords: adipocytes; adipose tissue; exercise; myostatin; physical activity; skeletal muscle.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / metabolism
  • Adult
  • Aged
  • Arrhythmias, Cardiac
  • Blood Glucose / physiology
  • Blotting, Western
  • Down-Regulation
  • Energy Metabolism / physiology*
  • Exercise / physiology*
  • Genetic Diseases, X-Linked
  • Gigantism
  • Glucose / metabolism
  • Glucose Clamp Technique
  • Heart Defects, Congenital
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Insulin Resistance / physiology
  • Intellectual Disability
  • Male
  • Middle Aged
  • Muscle Cells / metabolism*
  • Muscle, Skeletal / metabolism*
  • Myostatin / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Blood Glucose
  • Myostatin
  • Glucose

Supplementary concepts

  • Simpson-Golabi-Behmel syndrome